| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de28672dc91f8e69f8e1514cf5e5ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37590ac24be91dc1eef939c72627c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161a05ccb966f3a56f7c68d1c34717f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8e0253719edf1b6ead736a726232c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf9c9dddbc393f4ef10c2d70ada808c |
| publicationDate |
2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2993858-C |
| titleOfInvention |
Combination of rivaroxaban and acetylsalicylic acid for reducing the risk of cardiovascular events |
| abstract |
Combination therapy with rivaroxaban and Aspirin.TM. successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease. |
| priorityDate |
2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |